Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial by Audeh, M William, Dr, Carmichael, James, Prof, Penson, Richard T, MD, Friedlander, Michael, Prof, Powell, Bethan, Prof, Bell-McGuinn, Katherine M, PhD, Scott, Clare, MD, Weitzel, Jeffrey N, Prof, Oaknin, Ana, MD, Loman, Niklas, MD, Lu, Karen, Prof, Schmutzler, Rita K, Prof, Matulonis, Ursula, MD, Wickens, Mark, BSc, Tutt, Andrew, PhD

Get full text